cgp 12177 has been researched along with sq-11725 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, JG | 1 |
| Berdeaux, A; Bévérelli, F; Gauthier, C; Le Marec, H; Leblais, V; Rautureau, Y; Trochu, JN | 1 |
| Horinouchi, T; Koike, K | 1 |
| Balligand, JL; Donckier, JE; Gauthier, C; Heyndrickx, GR; Massart, PE; Van Mechelen, H | 1 |
| Beigi, F; Chakir, K; Wainer, IW; Xiao, RP | 1 |
| Hirouchi, M; Katsura, M; Ohkuma, S; Shibasaki, M; Tsujimura, A | 1 |
6 other study(ies) available for cgp 12177 and sq-11725
| Article | Year |
|---|---|
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Isoproterenol; Male; Nadolol; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phenylephrine; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes; Vasoconstriction; Vasodilation | 1999 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Aorta; Atropine Derivatives; Blood Pressure; Bupranolol; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Hexamethonium; Hypertension, Renal; Lipolysis; Myocardial Contraction; Nadolol; Propanolamines; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes; Time Factors | 2001 |
G-protein-coupled receptor chromatographic stationary phases. 2. Ligand-induced conformational mobility in an immobilized beta2-adrenergic receptor.
Topics: Adrenergic beta-Antagonists; Animals; Binding Sites; Butoxamine; Cell Line; Chromatography, Affinity; Ligands; Membrane Proteins; Mice; Nadolol; Propanolamines; Propranolol; Protein Conformation; Receptors, Adrenergic; Receptors, G-Protein-Coupled; Time Factors | 2004 |
Expression of beta-adrenergic receptor up-regulation is mediated by two different processes.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Blotting, Western; Cells, Cultured; Cerebral Cortex; Cycloheximide; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Mice; Nadolol; Neurons; Propanolamines; Protein Binding; Protein Synthesis Inhibitors; Receptors, Adrenergic, beta; RNA, Messenger; Signal Transduction; Time Factors; Tritium; Up-Regulation | 2006 |